Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Myrtle, Davis"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Chronic heart failure is one of the most common reasons for hospitalization. Current risk stratification is based on ejection fraction, whereas many arrhythmic events occur in patients with relatively preserved ejection fraction. We aim to i
Externí odkaz:
https://doaj.org/article/43cca5dad2664f589693f4ff85780c14
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/d625b10c3a414738b9793d7a35b890ab
Autor:
Lori M. Minasian, MD, Eileen Dimond, RN, MS, Myrtle Davis, DVM, PhD, ATS, Bishow Adhikari, PhD, Richard Fagerstrom, PhD, Carol Fabian, MD, Justin Floyd, DO, Joseph M. Unger, PhD, MS, Pamela S. Douglas, MD, Karen M. Mustian, PhD, MPH, Eric J. Chow, MD, MPH, Steven Lipshultz, MD, W. Gregory Hundley, MD, Saro H. Armenian, DO, MPH, Bonnie Ky, MD, MSCE
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outco
Externí odkaz:
https://doaj.org/article/c9974a1a47d043b78c7cfd5e8ff19334
Autor:
Ivan Rusyn, Courtney Sakolish, Yuki Kato, Clifford Stephan, Leoncio Vergara, Philip Hewitt, Vasanthi Bhaskaran, Myrtle Davis, Rhiannon N Hardwick, Stephen S Ferguson, Jason P Stanko, Piyush Bajaj, Karissa Adkins, Nisha S Sipes, E Sidney Hunter, Maria T Baltazar, Paul L Carmichael, Kritika Sadh, Richard A Becker
Publikováno v:
Toxicol Sci
Much has been written and said about the promise and excitement of microphysiological systems, miniature devices that aim to recreate aspects of human physiology on a chip. The rapid explosion of the offerings and persistent publicity placed high exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5fe00b5247331ff1b276233e30fd420
https://pubmed.ncbi.nlm.nih.gov/35689632
https://pubmed.ncbi.nlm.nih.gov/35689632
Autor:
Myrtle Davis, Dane R. Liston
Approved and marketed drugs are frequently studied in nonclinical models to evaluate the potential application to additional disease indications or to gain insight about molecular mechanisms of action. A survey of the literature reveals that nonclini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5566986c16fd51a6708ee9bd7649ab4
https://doi.org/10.1158/1078-0432.c.6526332
https://doi.org/10.1158/1078-0432.c.6526332
Autor:
Myrtle Davis, Dane R. Liston
An Excel file containing all small molecule drugs presented in Tables 1, 2 and 4 of the printed manuscript, including additional fields containing mechanism of action/target, MW, dose schedule, Tmax, Clearance, Volume of distribution, year approved,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612a29e240f6df64a717786ee2d81d27
https://doi.org/10.1158/1078-0432.22466502.v1
https://doi.org/10.1158/1078-0432.22466502.v1
Autor:
Myrtle Davis, Dane R. Liston
An Excel file containing all biological drugs presented in Table 3 of the printed manuscript, including additional fields containing mechanism of action/target, MW, dose schedule, Clearance, Volume of distribution, year approved, full references to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259bc3902a991b90d196b1c4a346806c
https://doi.org/10.1158/1078-0432.22466499.v1
https://doi.org/10.1158/1078-0432.22466499.v1
Autor:
Jean-Charles Gautier, Myrtle Davis, Douglas A. Keller, Niresh Hariparsad, Jonathan A. Phillips, Radhakrishna Sura, Taraka Sai Pavan Grandhi, Terry R. Van Vleet
Publikováno v:
Lab on a Chip. 20:468-476
The human kidney contains approximately one million nephrons. As the functional unit of the kidney, the nephron affords an opportunity to approximate the kidney at a microphysiological scale. Recent emergence of physiologically accurate human tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de840a616151794554b2a7cfe1beb0ca
https://doi.org/10.1039/c9lc00925f
https://doi.org/10.1039/c9lc00925f
Autor:
Michael W, Gill, Brian J, Murphy, Peter T W, Cheng, Lakshmi, Sivaraman, Myrtle, Davis, Lois, Lehman-McKeeman
Publikováno v:
Toxicology and applied pharmacology. 438
In a Phase 2 clinical trial, BMS-986020, a lysophosphatidic acid receptor-1 (LPA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c05a729d9cdd63ca5548b19a44a3985d
https://pubmed.ncbi.nlm.nih.gov/35090952
https://pubmed.ncbi.nlm.nih.gov/35090952
Autor:
Eileen P. Dimond, Bonnie Ky, Myrtle Davis, Eric J. Chow, W. Gregory Hundley, Pamela S. Douglas, Richard Fagerstrom, Carol J. Fabian, Joseph M. Unger, Karen M. Mustian, Justin D. Floyd, Saro H. Armenian, Lori M. Minasian, Bishow B. Adhikari, Steven E. Lipshultz
Publikováno v:
JACC CardioOncol
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d71e696b3af012edd05927a87e61d15
https://doi.org/10.1016/j.jaccao.2019.08.007
https://doi.org/10.1016/j.jaccao.2019.08.007